Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yang, Chengzhi ^a   Tian, Aiju ^a   Li, Zijian ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BIOCOMPATIBLE COATED MATERIAL; BIOLOGICAL MARKER; CYTOKINE; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE;

ANIMAL; BIOLOGICAL MODEL; CARDIAC MUSCLE; CARDIOMEGALY; CHEMISTRY; DISEASE MODEL; FIBROSIS; HEART FUNCTION TEST; INFLAMMATION; METABOLISM; MOUSE; PARTICLE SIZE; PATHOLOGY; PATHOPHYSIOLOGY; ULTRASTRUCTURE;

ANIMALS; BIOMARKERS; CARDIOMEGALY; COATED MATERIALS, BIOCOMPATIBLE; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROSIS; GOLD; HEART FUNCTION TESTS; INFLAMMATION; INFLAMMATION MEDIATORS; METAL NANOPARTICLES; MICE; MODELS, BIOLOGICAL; MYOCARDIUM; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

EID: 84957578170     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep20203     Document Type: Article

References (40)

1. Petros, R. A. &DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9, 615-627, doi: nrd2591 (2010
2. Ryu, J. H. et al. Theranostic nanoparticles for future personalized medicine. J Control Release 190, 477-484, doi: S0168-3659(14)00245-4 (2014)
3. Matsumura, Y. The drug discovery by nanomedicine and its clinical experience. Jpn J Clin Oncol 44, 515-525, doi: hyu046 (2014
4. Papasani, M. R., Wang, G. &Hill, R. A. Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. Nanomedicine 8, 804-814, doi: S1549-9634(12)00015-9 (2012
5. Khan, M. S., Vishakante, G. D. &Siddaramaiah, H. Gold nanoparticles: a paradigm shift in biomedical applications. Adv Colloid Interface Sci 199-200, 44-58, doi: S0001-8686(13)00069-9 (2013
6. Herizchi, R., Abbasi, E., Milani, M. &Akbarzadeh, A. Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol 1-7, doi: 10.3109/21691401.2014.971807 (2014
7. Nakanishi, J. et al. Light-regulated activation of cellular signaling by gold nanoparticles that capture and release amines. J Am Chem Soc 131, 3822-3823, doi: 10.1021/ja809236a (2009
8. Agasti, S. S. et al. Photoregulated release of caged anticancer drugs from gold nanoparticles. J Am Chem Soc 131, 5728-5729, doi: 10.1021/ja900591t (2009
9. Francois, A. et al. Encapsulation of docetaxel into PEGylated gold nanoparticles for vectorization to cancer cells. ChemMedChem 6, 2003-2008, doi: 10.1002/cmdc.201100311 (2011
10. Eustis, S. &el-Sayed, M. A. Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes. Chem Soc Rev 35, 209-217, doi: 10.1039/b514191e (2006
11. Whitesides, G. M. The 'right' size in nanobiotechnology. Nat Biotechnol 21, 1161-1165, doi: 10.1038/nbt872 (2003
12. Oberdorster, G., Oberdorster, E. &Oberdorster, J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113, 823-839 (2005
13. Khlebtsov, N. &Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 40, 1647-1671, doi: 10.1039/c0cs00018c (2011
14. Cho, W. S. et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236, 16-24, doi: S0041-008X(08)00532-2 (2009
15. Abdelhalim, M. A. &Jarrar, B. M. Gold nanoparticles administration induced prominent inflammatory, central vein intima disruption, fatty change and Kupffer cells hyperplasia. Lipids Health Dis 10, 133, doi: 1476-511X-10-133 (2011
16. Cho, W. S. et al. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245, 116-123, doi: S0041-008X(10)00072-4 (2010)
17. Yang, H. et al. Effects of gestational age and surface modification on materno-fetal transfer of nanoparticles in murine pregnancy. Sci. Rep. 2, 847, doi: 10.1038/srep00847 (2012
18. Abdelhalim, M. A. Exposure to gold nanoparticles produces cardiac tissue damage that depends on the size and duration of exposure. Lipids Health Dis 10, 205, doi: 1476-511X-10-205 (2011
19. Vinodhini, A., Govindaraju, K., Singaravelu, G., Sadiq, A. M. &Kumar, V. G. Cardioprotective potential of biobased gold nanoparticles. Colloids Surf B Biointerfaces 117, 480-486, doi: S0927-7765(14)00007-1 (2014
20. Yang, C. et al. No overt structural or functional changes associated with PEG-coated gold nanoparticles accumulation with acute exposure in the mouse heart. Toxicol Lett 222, 197-203, doi: S0378-4274(13)01228-9 (2013
21. Sonavane, G., Tomoda, K. &Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66, 274-280, doi: S0927-7765(08)00269-5 (2008
22. Coradeghini, R. et al. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol Lett 217, 205-216, doi: S0378-4274(12)01402-6 (2013
23. Upadhyayula, V. K. Functionalized gold nanoparticle supported sensory mechanisms applied in detection of chemical and biological threat agents: a review. Anal Chim Acta 715, 1-18, doi: S0003-2670(11)01673-4 (2012
24. Albanese, A., Tang, P. S. &Chan, W. C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14, 1-16, doi: 10.1146/annurev-bioeng-071811-150124 (2012
25. Veronese, F. M. &Pasut, G. PEGylation, successful approach to drug delivery. Drug Discov Today 10, 1451-1458, doi: S1359-6446(05)03575-0 (2005)
26. Rahme, K., Guo, J., Holmes, J. D. &O'Driscoll, C. M. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery. Colloids Surf B Biointerfaces 135, 604-612, doi: S0927-7765(15)30148-X (2015
27. Jain, P. K., Lee, K. S., El-Sayed, I. H. &El-Sayed, M. A. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B 110, 7238-7248, doi: 10.1021/jp057170o (2006
28. Burlew, B. S. &Weber, K. T. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin 18, 435-442 (2000
29. Weber, K. T., Sun, Y., Tyagi, S. C. &Cleutjens, J. P. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26, 279-292, doi: S0022-2828(84)71036-4 (1994
30. Frangogiannis, N. G. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol 11, 255-265, doi: nrcardio.2014.28 (2014
31. Sadauskas, E. et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4, 10, doi: 1743-8977-4-10 (2007)
32. Kennedy, L. C. et al. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 7, 169-183, doi: 10.1002/ smll.201000134 (2011
33. Lasagna-Reeves, C. et al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 393, 649-655, doi: S0006-291X(10)00257-3 (2010
34. Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C. &Chan, W. C. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 9, 1909-1915, doi: 10.1021/nl900031y (2009
35. De Jong, W. H. et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29, 1912-1919, doi: S0142-9612(07)01071-X (2008
36. Bruhn, B. R. et al. Osmosis-based pressure generation: dynamics and application. PLoS One 9, e91350, doi: 10.1371/journal. pone.0091350 (2014
37. Starling, E. H. On the Absorption of Fluids from the Connective Tissue Spaces. J Physiol 19, 312-326 (1896
38. Thakor, A. S., Jokerst, J., Zavaleta, C., Massoud, T. F. &Gambhir, S. S. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett 11, 4029-4036, doi: 10.1021/nl202559p (2011
39. Ujfalussy, I., Koo, E., Sesztak, M. &Gergely, P. Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases. Z Rheumatol 62, 155-160, doi: 10.1007/s00393-003-0458-2 (2003
40. van Nieuwenhoven, F. A. &Turner, N. A. The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction. Vascul Pharmacol 58, 182-188, doi: S1537-1891(12)00129-2 (2013